O-GlcNAcase-IN-3
O-GlcNAcase-IN-3 (Compound I) is an OGA inhibitor. O-GlcNAcase-IN-3 can be used for Alzheimer's Disease (AD) research[1].
Product Specifications
CAS Number
[2760514-33-6]
UNSPSC
12352005
Target
OGA
Related Pathways
Neuronal Signaling
Field of Research
Neurological Disease
Smiles
COC1=NC=NC(O[C@@H]2C[C@H](C)N(CC3=C(F)N=C(NC(C)=O)S3)C2)=C1.O[C@H]([C@@H](O)C(O)=O)C(O)=O
Molecular Formula
C20H26FN5O9S
Molecular Weight
531.51
References & Citations
[1]NERY O'DONNELL F C, et al. N-[4-fluor-5-[[ (2s, 4 r) -4-[ (6-methoxy-4-pyrimidinyl) oxy]- 2-methyl-1-pyrrolidinyl] methyl ]-2-thiazolyl]acetamid for use in the treatment of alzheimer disease. WO2025184490A1. 2025-09-04.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
M2250-09 100 µL
Mannan Binding Protein (MBP, Mannose Binding Protein, Mannan Binding Lectin, MBL) discontinued
Ask
View Details 
GTR15179187 1 Vial
Lentiviral mouse Minpp1 shRNA (UAS) - Lentiviral mouse Minpp1 shRNA (UAS, iRFP) (100)
Ask
View Details